Income Before Tax

Pre-Tax Income (Domestic)

Vertex Pharmaceuticals Pre-Tax Income (Domestic) remained flat by 0.0% to $705.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 306.0%, from -$342.43M to $705.30M. Over 2 years (FY 2023 to FY 2025), Pre-Tax Income (Domestic) shows relatively stable performance with a -4.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Higher values indicate strong domestic market performance and operational efficiency within the home country.

Detailed definition

The portion of income from continuing operations generated within the company's home country before the deduction of inc...

Peer comparison

Commonly reported by multinational corporations to distinguish domestic tax bases from foreign earnings.

Metric ID: is_msft_income_before_tax_domestic

Historical Data

3 years
 FY'23FY'24FY'25
Value$3.09B-$1.37B$2.82B
YoY Change—-144.3%+306.0%
Range-$1.37B – $3.09B
CAGR-4.4%
Avg YoY Growth+80.8%
Median YoY Growth+80.8%

Frequently Asked Questions

What is Vertex Pharmaceuticals's pre-tax income (domestic)?
Vertex Pharmaceuticals (VRTX) reported pre-tax income (domestic) of $705.30M in Q4 2025.
How has Vertex Pharmaceuticals's pre-tax income (domestic) changed year-over-year?
Vertex Pharmaceuticals's pre-tax income (domestic) increased by 306.0% year-over-year, from -$342.43M to $705.30M.
What is the long-term trend for Vertex Pharmaceuticals's pre-tax income (domestic)?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's pre-tax income (domestic) has grown at a -4.4% compound annual growth rate (CAGR), from $3.09B to $2.82B.
What does pre-tax income (domestic) mean?
Pre-tax profit generated specifically from domestic business operations.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.